Glaukos (US.GKOS)
Capital Allocation Audit · Period: 2013 – 2026
Key Metrics
US.GKOS · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | -191.6% | ↓ |
| ROE | -5.6% | ↓ |
| Cash Conversion | - | → |
| D/E Ratio | 0.15 | ↓ |
| Gross Margin | 80.0% | → |
US.GKOS (Glaukos) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ----------------------------- FCF Conversion -191.6% ↓ ROE -5.6% ↓ Cash Conversion - → D/E Ratio 0.15 ↓ Gross Margin 80.0% →
Key Metrics
US.GKOS (Glaukos) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY-----------------------------FCF Conversion -191.6% ↓ROE -5.6% ↓Cash Conversion - →D/E Ratio 0.15 ↓Gross Margin 80.0% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies